Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
340 participants
INTERVENTIONAL
2022-05-24
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate the efficacy of this intervention, pediatric patients are invited to participate in repeat evaluations within 2 weeks, 3 months, 6 months, and 12 months after their well-child visit. The study will evaluate the following: 1) the association between Child-ACE scores and biomarkers of toxic stress at baseline in children age 3-11 years old; 2) whether the intervention reduces toxic stress and child health and psychosocial problems at follow-up for children with ACEs compared to usual well-child care for children with ACEs; and 3) the impact of mediating and moderating variables. These results will demonstrate that for families with ACEs the intervention will decrease toxic stress associated with ACEs, improve health outcomes, and reduce health disparities.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of Adverse Childhood Experiences (ACEs) Policy
NCT04916587
Mitigating ACEs in Pediatric Primary Care
NCT03058861
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness
NCT04273126
The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children
NCT05129501
Resilient Families Open Pilot: Dyadic Resiliency Intervention
NCT06239571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Three-Tier Model
130 children with ACEs who received well-child care by a trained provider will be enrolled in this group.
Three-Tier Model
Families in the intervention will be counseled by a pediatric provider about ACEs, resilience, stress management, and healthy relationships. Families will also be referred to community health workers and parenting educators.
Comparison Group
80 children without ACEs who received usual well-child care will be enrolled in this group.
No interventions assigned to this group
Control Group
130 children with ACEs who received usual well-child care will be enrolled in this group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three-Tier Model
Families in the intervention will be counseled by a pediatric provider about ACEs, resilience, stress management, and healthy relationships. Families will also be referred to community health workers and parenting educators.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Seen for a well-child visit at a participating pediatric clinic
Exclusion Criteria
* Significant congenital medical problems
* Previous participation in parenting program (last 12 months)
* Sibling enrollment in current study
3 Years
11 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ariane Marie-Mitchell, MD, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ariane Marie-Mitchell, MD, PhD, MPH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5180358
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.